Guest Author - Linda Reid

Aspirin as an Adjunct for Treatment of Breast and Colorectal Cancer

Recent studies have indicated that breast and colorectal cancer survivors reduce the risk of a recurrence of the disease if they take aspirin as part of a preventative health regimen.

Aspirin (acetylsalicylic acid) is well known for its ability to relieve pain and reduce fever and because this simple, yet highly effective drug has been around for so many generations, its long-term effects are well documented. It is one of the safest drugs to take compared to more recent analgesics (pain relievers) that do not yet have a proven track record.

The protective effects of aspirin against cancer seem to be linked to its anti-inflammatory properties. It has long been suspected that chronic inflammation may lead to cancer as it provides conditions in which abnormal cells can duplicate and survive. Aspirin reduces inflammation and creates a less friendly environment for the growth of tumours.

Avoiding Recurrence

Studies have shown that the recurrence of breast cancer and colon polyps is significantly reduced in individuals taking aspirin. One study showed a drop in the mortality rate of an impressive 71 percent for breast cancer survivors taking aspirin between two and five times per week. Another study indicates that colorectal cancer survivors taking aspirin decreased their risk of death from the disease by nearly 30 percent.

Don’t Jump on the Bandwagon Just Yet

It’s important to note that while these studies are encouraging, aspirin comes with side-effects including gastrointestinal bleeding and tinnitus (ringing in the ears). It is also not recommended for people with blood-clotting disorders, liver and kidney disease and high blood pressure.

Diligence Saves Lives

Aspirin cannot replace conventional treatments for breast and colorectal cancer. Thanks to cancer research, recent discoveries have produced treatments so effective that 90 percent of women diagnosed with breast cancer will survive for at least five years after their diagnosis. If colorectal cancer is detected early, there is a 91 percent survival rate.

Optimistic survival rate figures are dependent on early detection and treatment. While science continues to come up with new and better ways to treat cancer, the onus is still on the individual to be diligent about health check-ups. Nobody likes having their breast squished into a vice or a tube stuck up their behind but comparing a half hour of minor discomfort to months of costly and painful treatment and possibly, death, the choice to make is an obvious one.